-
Je něco špatně v tomto záznamu ?
Associations of plasma phospholipid cis-vaccenic acid with insulin resistance markers in non-diabetic men with hyperlipidemia
J. Macášek, B. Staňková, A. Žák, M. Růžičková, R. Brůha, S. Kutová, M. Vecka, M. Zeman
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
Charles University Research Program, Cooperatio-Gastroenterology
Ministerstvo Školství, Mládeže a Tělovýchovy (Ministry of Education, Youth and Sports)
Charles University Research Program, Cooperatio-Gastroenterology
Ministerstvo Školství, Mládeže a Tělovýchovy (Ministry of Education, Youth and Sports)
Charles University Research Program, Cooperatio-Gastroenterology
Ministerstvo Školství, Mládeže a Tělovýchovy (Ministry of Education, Youth and Sports)
Charles University Research Program, Cooperatio-Gastroenterology
Ministerstvo Školství, Mládeže a Tělovýchovy (Ministry of Education, Youth and Sports)
MH CZ DRO-VFN64165
Ministerstvo Zdravotnictví Ceské Republiky (Ministry of Health of the Czech Republic)
MH CZ DRO-VFN64165
Ministerstvo Zdravotnictví Ceské Republiky (Ministry of Health of the Czech Republic)
MH CZ DRO-VFN64165
Ministerstvo Zdravotnictví Ceské Republiky (Ministry of Health of the Czech Republic)
NU23-01-00288
Ministerstvo Zdravotnictví Ceské Republiky (Ministry of Health of the Czech Republic)
MH CZ DRO-VFN64165
Ministerstvo Zdravotnictví Ceské Republiky (Ministry of Health of the Czech Republic)
NLK
Directory of Open Access Journals
od 2011
Free Medical Journals
od 2011
Nature Open Access
od 2011-01-01
PubMed Central
od 2011
Europe PubMed Central
od 2011
ProQuest Central
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Health & Medicine (ProQuest)
od 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2010
Springer Nature OA/Free Journals
od 2011-01-01
- MeSH
- apolipoproteiny B krev MeSH
- biologické markery * krev MeSH
- dospělí MeSH
- fosfolipidy * krev MeSH
- hyperlipidemie * krev MeSH
- inzulin krev MeSH
- inzulinová rezistence * MeSH
- kyseliny olejové * krev MeSH
- lidé středního věku MeSH
- lidé MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND: The role of fatty acids (FA) in the pathogenesis of insulin resistance and hyperlipidemia is a subject of intensive research. Several recent works have suggested cis-vaccenic acid (cVA) in plasma lipid compartments, especially in plasma phospholipids (PL) or erythrocyte membranes, could be associated with markers of insulin sensitivity and cardiovascular health. Nevertheless, not all the results of research work testify to these beneficial effects of cVA. Therefore, we decided to investigate the relations of proportion of cVA in plasma PL to markers of insulin resistance in hyperlipidemic men. SUBJECTS: In 231 men (median age 50) with newly diagnosed hyperlipidemia, we analyzed basic clinical parameters together with FA composition of plasma PL and stratified them according to the content of cVA into upper quartile (Q4) and lower quartile (Q1) groups. We examined also small control group of 50 healthy men. RESULTS: The individuals in Q4 differed from Q1 by lower plasma insulin (p < 0.05), HOMA-IR values (p < 0.01), and apolipoprotein B concentrations (p < 0.001), but by the higher total level of nonesterified FA (p < 0.01). Both groups had similar age, anthropometrical, and other lipid parameters. In plasma PL, the Q4 group had lower content of the sum of n-6 polyunsaturated FA, due to decrease of γ-linolenic and dihomo-γ-linolenic acids, whereas the content of monounsaturated FA (mainly oleic and palmitoleic) was in Q4 higher. CONCLUSIONS: Our results support hypothesis that plasma PL cVA could be associated with insulin sensitivity in men with hyperlipidemia.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24018934
- 003
- CZ-PrNML
- 005
- 20241024111201.0
- 007
- ta
- 008
- 241015s2024 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41387-024-00332-z $2 doi
- 035 __
- $a (PubMed)39261487
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Macášek, Jaroslav $u Fourth Department of Internal Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, U Nemocnice 2, 128 08, Prague, Czech Republic
- 245 10
- $a Associations of plasma phospholipid cis-vaccenic acid with insulin resistance markers in non-diabetic men with hyperlipidemia / $c J. Macášek, B. Staňková, A. Žák, M. Růžičková, R. Brůha, S. Kutová, M. Vecka, M. Zeman
- 520 9_
- $a BACKGROUND: The role of fatty acids (FA) in the pathogenesis of insulin resistance and hyperlipidemia is a subject of intensive research. Several recent works have suggested cis-vaccenic acid (cVA) in plasma lipid compartments, especially in plasma phospholipids (PL) or erythrocyte membranes, could be associated with markers of insulin sensitivity and cardiovascular health. Nevertheless, not all the results of research work testify to these beneficial effects of cVA. Therefore, we decided to investigate the relations of proportion of cVA in plasma PL to markers of insulin resistance in hyperlipidemic men. SUBJECTS: In 231 men (median age 50) with newly diagnosed hyperlipidemia, we analyzed basic clinical parameters together with FA composition of plasma PL and stratified them according to the content of cVA into upper quartile (Q4) and lower quartile (Q1) groups. We examined also small control group of 50 healthy men. RESULTS: The individuals in Q4 differed from Q1 by lower plasma insulin (p < 0.05), HOMA-IR values (p < 0.01), and apolipoprotein B concentrations (p < 0.001), but by the higher total level of nonesterified FA (p < 0.01). Both groups had similar age, anthropometrical, and other lipid parameters. In plasma PL, the Q4 group had lower content of the sum of n-6 polyunsaturated FA, due to decrease of γ-linolenic and dihomo-γ-linolenic acids, whereas the content of monounsaturated FA (mainly oleic and palmitoleic) was in Q4 higher. CONCLUSIONS: Our results support hypothesis that plasma PL cVA could be associated with insulin sensitivity in men with hyperlipidemia.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 12
- $a inzulinová rezistence $7 D007333
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a biologické markery $x krev $7 D015415
- 650 12
- $a fosfolipidy $x krev $7 D010743
- 650 12
- $a hyperlipidemie $x krev $7 D006949
- 650 _2
- $a dospělí $7 D000328
- 650 12
- $a kyseliny olejové $x krev $7 D009829
- 650 _2
- $a inzulin $x krev $7 D007328
- 650 _2
- $a apolipoproteiny B $x krev $7 D001055
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Staňková, Barbora $u Fourth Department of Internal Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, U Nemocnice 2, 128 08, Prague, Czech Republic $u Institute of Clinical Chemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Na Bojišti 3, 121 08, Prague, Czech Republic
- 700 1_
- $a Žák, Aleš $u Fourth Department of Internal Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, U Nemocnice 2, 128 08, Prague, Czech Republic
- 700 1_
- $a Růžičková, Markéta $u Fourth Department of Internal Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, U Nemocnice 2, 128 08, Prague, Czech Republic
- 700 1_
- $a Brůha, Radan $u Fourth Department of Internal Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, U Nemocnice 2, 128 08, Prague, Czech Republic
- 700 1_
- $a Kutová, Simona $u Fourth Department of Internal Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, U Nemocnice 2, 128 08, Prague, Czech Republic
- 700 1_
- $a Vecka, Marek $u Fourth Department of Internal Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, U Nemocnice 2, 128 08, Prague, Czech Republic. marek.vecka@lf1.cuni.cz $u Institute of Clinical Chemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Na Bojišti 3, 121 08, Prague, Czech Republic. marek.vecka@lf1.cuni.cz $1 https://orcid.org/0000000232691817 $7 xx0076497
- 700 1_
- $a Zeman, Miroslav $u Fourth Department of Internal Medicine, First Faculty of Medicine, Charles University and General University Hospital in Prague, U Nemocnice 2, 128 08, Prague, Czech Republic
- 773 0_
- $w MED00181736 $t Nutrition & diabetes $x 2044-4052 $g Roč. 14, č. 1 (2024), s. 73
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39261487 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20241015 $b ABA008
- 991 __
- $a 20241024111155 $b ABA008
- 999 __
- $a ok $b bmc $g 2201659 $s 1230907
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 14 $c 1 $d 73 $e 20240911 $i 2044-4052 $m Nutrition & diabetes $n Nutr Diabetes $x MED00181736
- GRA __
- $a Charles University Research Program, Cooperatio-Gastroenterology $p Ministerstvo Školství, Mládeže a Tělovýchovy (Ministry of Education, Youth and Sports)
- GRA __
- $a Charles University Research Program, Cooperatio-Gastroenterology $p Ministerstvo Školství, Mládeže a Tělovýchovy (Ministry of Education, Youth and Sports)
- GRA __
- $a Charles University Research Program, Cooperatio-Gastroenterology $p Ministerstvo Školství, Mládeže a Tělovýchovy (Ministry of Education, Youth and Sports)
- GRA __
- $a Charles University Research Program, Cooperatio-Gastroenterology $p Ministerstvo Školství, Mládeže a Tělovýchovy (Ministry of Education, Youth and Sports)
- GRA __
- $a MH CZ DRO-VFN64165 $p Ministerstvo Zdravotnictví Ceské Republiky (Ministry of Health of the Czech Republic)
- GRA __
- $a MH CZ DRO-VFN64165 $p Ministerstvo Zdravotnictví Ceské Republiky (Ministry of Health of the Czech Republic)
- GRA __
- $a MH CZ DRO-VFN64165 $p Ministerstvo Zdravotnictví Ceské Republiky (Ministry of Health of the Czech Republic)
- GRA __
- $a NU23-01-00288 $p Ministerstvo Zdravotnictví Ceské Republiky (Ministry of Health of the Czech Republic)
- GRA __
- $a MH CZ DRO-VFN64165 $p Ministerstvo Zdravotnictví Ceské Republiky (Ministry of Health of the Czech Republic)
- LZP __
- $a Pubmed-20241015